Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa

AIDS

Volumn 12, Issue 8, 1998, Pages 939-948

  Marseille, Elliot ^a,d   Kahn, James G ^b   Saba, Joseph ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNAIDS   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Africa; AIDS; Children; Cost effectiveness; HIV 1; Mother to child transmission

Indexed keywords

ANTIVIRUS AGENT; LAMIVUDINE; ZIDOVUDINE;

AFRICA SOUTH OF THE SAHARA; ARTICLE; COST EFFECTIVENESS ANALYSIS; DISABILITY; DRUG COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0032574897     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199808000-00017     Document Type: Article

References (28)

1. Conner EM, Sperling RS, Gelber R, et al. for the Pediatric AIDS Clinical Trial Group Protocol 076 Study Group: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.
2. Mertens TE, low-Beer D: HIV and AIDS: where is the epidemic going? Bull World Health Organ 1996, 74:121-129.
3. Miotti PG., Chiphangwi JD, Dallabetta GA: The situation in Africa. Ballieres Clin Obst Cynaerol 1992, 6:165-186.
4. Alien S, Van de Perre P, Serufilira A, et al.: HIV and malaria in a representative sample of childbearing women in Rwanda. J Infect Dis 1991, 164:67-71.
5. Black RF: Transmission of HIV-1 in the breast-feeding process. J Am Diet Assoc 1996, 96:267-276.
6. Dunn DT, Newell, ML, Ades AE, et al.: Risk of human immunodeficiency virus type 1 transmission through breast feeding. Lancet 1992, 340:585-588.
7. Van de Perre P: Postnatal transmission of human immunodeficiency virus type 1: the breastfeeding dilemma. Am J Obstet Gynecol 1995, 173:483-487.
8. UNICEF: The State of the World's Children, 1995. New York: Oxford University Press; 1995.
9. World Bank: World Development Report, 1994. New York: Oxford University Press; 1995.
10. Nicoll A, Newell ML: Preventing perinatal transmission of HIV: the effect of breast-feeding [letter]. JAMA 276:1562.
11. Anon: 1996 Essential Directory of Pharmaceuticals, First Data Bank: Blue Book. New York City: Hearst Corporation; 1996.
12. Laing R, Pallango K: Background Study on Alternative Approaches to Managing the Opportunistic Illnesses of HIV-Infected Persons: Costs and Burdens on the Tanzanian Health Care System [Prepared for Tanzania AIDS Assessment and Planning Study]. Washington, DC: International Bank for Reconstuction and Development/World Bank; 1990.
13. Davichi F, Baudoux P, Ndoko K, N'Galy B, Mann J: The Economic Impact on Families of Children with AIDS in Kinshasa, Zaire. The Global Impact of AIDS. Edited by Fleming A, Carballo M, FitzSimons Bailey M, Mann J. New York: Alan R Liss; 1988:167-169.
14. Murray CJL, Govindaraj R, Husgrove P: National health expenditures: a global analysis. Bull World Health Organ 1994, 72:623-637.
15. Mansergh G, Haddix AC, Steketee RW, et al.: Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA 1996, 276:139-145.
16. Murray CLJ, Lopez AD (Eds): Table 3. Age-specific disability weights for untreated and treated forms of sequalae included in the Global Burden of Disease Study. In The Global Burden of Disease, Annex. Boston: Harvard School of Public Health; 1996.
17. Murray CLJ: Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994, 72:429-445.
18. World Bank: World Development Report, 1993. New York: Oxford University Press; 1993.
19. Haub C, Yanagashita M: 1996 World Population Data Sheet. Washington, DC: Population Reference Bureau, Inc.; 1996.
20. Chin J: The epidemiology and projected mortality of AIDS. In Disease and Mortality in Sub-Saharan Africa. Edited by Feachem RG, Jamison DT, Washington, DC: Oxford University Press; 1989.
21. Chin J, Sonnenberg F: The Lpidemiology and Projected Mortality of AIDS in the Republic of Tanzania [Background Paper Prepared for the Tanzania AIDS Assessment and Planning Study]. Washington, DC: World Bank; 1991.
22. Fylkesnes K, Brunborg H, Msiska R: The Socio-Economic Impact of AIDS. Background Paper 1. Zambia: The Current HIV/AIDS Situation and Future Demographic Impact, Lusaka: Ministry of Health; 1994.
23. Murray CJL, Govindaraj R, Musgrove P: National health expenditures: a global analysis. Bull World Health Organ 1994, 72:623-637.
24. Joint United Nations Programme on HIV/AIDS (UNAIDS): HIV/AIDS Lpidemiology in Africa [Fact Sheet]. Geneva; UNAIDS; May 1996.
25. International Program Center, Population Division, US Bureau of the Census: HIV/AIDS in Africa [Research Note No. 20]. Washington, DC: US Bureau of the Census; December 1995.
26. Gilson L, Mkanje R, Grosskurth H, et al.: Cost effectiveness of improved STD treatment services as a preventive intervention against HIV in Mwanza region, Tanzania. XI International Conference on AIDS. Vancouver, July 1996 [abstract C444].
27. Jamison DJ: Disease control priorities in developing countries: an overview. In Disease Control Priorities in Developing Countries. Edited by Jamison DT, Mosley W, Measham A, Bobadilla J. New York: Oxford University Press; 1993:3-29.
28. Warren KS, Bundy DAP, Anderson RW, et al.: Helminth infection. In Disease Control Priorities in Developing Countries. Edited by Jamison DT, Mosley W, Mensham A, Bobadilla J. New York: Oxford University Press; 1993:131-160.